30.05
price up icon10.28%   2.80
after-market 시간 외 거래: 30.05
loading

Enliven Therapeutics Inc (ELVN) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
36.62%
34.28
25.10 - 31.69 26.90
Operating Income/Loss
36.62%
-34.28
-25.10 - -31.69 -26.90
Nonoperating Income/Loss
6.67%
4.618
4.948 - 3.149 3.716
Income/Loss From Continuing Operations Before Tax
47.25%
-29.67
-20.15 -25.34 -28.54 -23.18
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
47.25%
-29.67
-20.15 -25.34 -28.54 -23.18
Net Income/Loss
47.25%
-29.67
-20.15 -25.34 -28.54 -23.18
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
96.99%
1.8701
62.09 - 50.05 0.9354
Diluted Average Shares
96.99%
1.8701
62.09 - 50.05 0.9354
Basic Earnings Per Share
50.00%
-0.48
-0.32 - -0.57 -0.46
Diluted Earnings Per Share
50.00%
-0.48
-0.32 - -0.57 -0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):